Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain

Neuroscience

Volumn 152, Issue 4, 2008, Pages 1032-1039

  Palkovits, M ^a   Harvey White, J ^b   Liu, J ^b   Kovacs, Z S ^c   Bobest, M ^d   Lovas, G ^e   Bago A G ^f   Kunos, G ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c UNIVERSITY OF WEST HUNGARY   (Hungary)

^d Markusovszky Teaching Hospital   (Hungary)

^e SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^f NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

Author keywords

2 arachidonoylglycerol; anandamide; brain microdissection; neurosurgical dissections

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ENDOCANNABINOID;

ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; LATERAL HYPOTHALAMUS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICRODISSECTION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD DORSAL HORN; TRIGEMINAL NUCLEUS;

ARACHIDONIC ACIDS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, LIQUID; FEMALE; GLYCERIDES; HUMANS; MALE; MASS SPECTROMETRY; MICRODISSECTION; POLYUNSATURATED ALKAMIDES; POSTMORTEM CHANGES; TIME FACTORS;

EID: 41549088666     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.01.034     Document Type: Article

References (29)

1. Aveldano M.I., and Bazan N.G. Rapid production of diacylglycerols enriched in arachidonate and stearate during early brain ischemia. J Neurochem 25 (1975) 919-920
2. Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Makriyannis A., Khanolkar A., Layward L., Fezza F., Bisogno T., and Di Marzo V. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 15 (2001) 300-302
3. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J., and Di Marzo V. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256 (1999) 372-380
4. Bisogno T., Martire A., Petrosino S., Popoli P., and Di Marzo V. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease. Neurochem Int (2007) 06-031 doi:10.1016/j.neuint.
5. Cabranes A., Venderova K., de Lago E., Fezza F., Sanchez A., Mestre L., Valenti M., Garcia-Merino A., Ramos J.A., Di Marzo V., and Fernandez-Ruiz J. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol Dis 20 (2005) 207-217
6. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98 (2001) 9371-9376
7. Devane W.A., Hanus L., Beuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Wetinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to cannabinoid receptor. Science 25 (1992) 1946-1949
8. Di Marzo V., Hill M.P., Bisogno T., Crossman A.R., and Brotchie J.M. Enhanced levels of endocannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14 (2000) 1432-1438
9. Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated hypothalamic endocannabinoids acting at CB1 receptors are involved in maintaining food intake. Nature 410 (2001) 822-825
10. Dinh T.P., Freund T.F., and Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 121 (2002) 149-158
11. Felder C.C., Nielsen A., Briley E.M., Palkovits M., Priller J., Axelrod J., Nguyen D.N., Richardson J.M., Riggin R.M., Koppel G.A., Paul S.M., and Becker G.W. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393 (1996) 231-235
12. Járai Z., Wagner J.A., Goparaju S.K., Wang L., Razdan R.K., Sugiura T., Zimmmer A.M., Bonner T.I., Zimmmer A., and Kunos G. Cardiovascular effects on 2-arachidonoyl glycerol in anesthetized mice. Hypertension 35 (2000) 679-684
13. Jo Y.H., Chen Y.J., Chua Jr. S.C., Talmage D.A., and Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48 (2005) 1055-1066
14. Kathuria S., Gaetani S., Fegley D., Valiño F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., and Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9 (2003) 76-81
15. Kempe K., Hsu F.F., Bohrer A., and Turk J. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptors, accumulates in rat brain tissue postmortem but is contained at low levels in or absent from fresh tissue. J Biol Chem 271 (1996) 17287-17295
16. Maccarrone M., Attiná M., Cartoni A., Bari M., and Finazzi-Agró A. Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. J Neurochem 76 (2001) 594-601
17. Maccarrone M., Gubellini P., Bari M., Picconi B., Battista N., Centonze D., Bernardi G., Finazzi-Agro A., and Calabresi P. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J Neurochem 85 (2003) 1018-1025
18. Mato S., and Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 46 (2004) 716-726
19. Matthew S.J., and Ho S. Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 67 Suppl 12 (2006) 9-13
20. McKinney M.K., and Cravatt B.F. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74 (2005) 411-434
21. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., Di Marzo V., Gessa G.L., and Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 24 (2004) 10707-10715
22. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target for pharmacotherapy. Pharmacol Rev 58 (2006) 592-658
23. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59 (1973) 449-450
24. Patel S., Carrier E.J., Ho W.S., Rademacher D.J., Cunningham S., Reddy D.S., Falck J.R., Cravatt B.F., and Hillard C.J. The postmortal accumulation of brain N-arachidonylethanolamine (anadamide) is dependent upon fatty acid amide hydrolase activity. J Lipid Res 46 (2005) 342-349
25. Perry E.K., and Perry E.H. Human brain neurochemistry. Some postmortem problems. Life Sci 33 (1983) 1733-1743
26. Schmid P.C., Krebsbach R.J., Perry S.R., Dettmer J.L., Maasson J.L., and Schmid H.H. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett 375 (1995) 143-147
27. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215 (1995) 89-97
28. Sugiura T., Yoshinaga N., and Waku K. Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci Lett 297 (2001) 175-178
29. Wang L., Liu J., Harvey-White J., Zimmer A., and Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100 (2003) 1393-1398